Internet-delivered Cognitive Behavior Therapy (CBT) for Children Age 8-12 Years With Anxiety Disorders

Internet-delivered Cognitive Behavior Therapy (CBT) Treatment for Anxiety Disorders in Children Age 8-12 Years - a Randomised Controlled Trial

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01533402

Enrollment

128

Registered

2012-02-15

Start date

2012-02-29

Completion date

2014-04-30

Last updated

2014-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorders

Keywords

Cognitive behavior therapy, Internet, Anxiety disorders, Children

Brief summary

The purpose of this study is to investigate whether a 10 week Internet-delivered CBT is a feasible approach to treat children (age 8-12 years) with anxiety disorder (social phobia, panic disorder, specific phobia, generalized anxiety disorder or separation anxiety disorder). The program is directed toward both the parents and children. The patients work with the treatment is supported through on-line contact with a therapist. Approximately 128 patients will be included in the study and randomized to either condition. All included patients are assessed before the treatment starts and after 10 weeks (post treatment). Follow-up assessments are conducted at 3 and 12 months after treatment.

Interventions

BEHAVIORALtherapist support

Weekly therapist support without CBT-interventions

BEHAVIORALInternet-delivered CBT

Internet-delivered cognitive behavioural therapy with therapist support

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

8 Years to 12 Years

Healthy volunteers

Inclusion criteria

* primary diagnosis of social phobia, panic disorder, specific phobia, generalized anxiety disorder or separation anxiety disorder, * age between 8 and 12 years, * ability to read and write Swedish and * with access to a computer and use of internet.

Exclusion criteria

* Presence of neuropsychiatric diagnosis or a primary psychiatric disorder other than those that the treatment aims at.

Design outcomes

Primary

Measure	Time frame	Description
Anxiety symptoms	two - three weeks pre treatment and 10 weeks, 3 months and 12 months post treatment	Change from baseline in anxiety symptoms. Clinician Severity Rating (CSR) assessed by a clinician with Anxiety Diagnostic Interview Schedule (ADIS C/P).

Secondary

Measure	Time frame	Description
Quality of Life	two weeks pre treatment and 10 weeks, 3 months and 12 months post treatment	Quality of Life (QOLI)
comorbidity	two - four weeks before treatment starts	Development and Wellbeing Assessment (DAWBA)
Depressive symptoms	two weeks pre treatment and 10 weeks, 3 months and 12 months post treatment	Children Depression Scale (CDI)
Anxiety symptoms	two weeks pre treatment and 10 weeks, 3 months and 12 months post treatment	Change from baseline in anxiety symptoms. Fear Survey Schedule for Children (FSSC-C/P).
Client Satisfaction Scale	two weeks before treatment and 10 weeks, 3 and 12 months post treatment	Client Satisfaction Scale (CSS)
Parental psychopathology	two weeks pre treatment	Primary Care Evaluation of Mental disorders (Prime-MD)
Funtional impairment	two weeks pre treatment and 10 weeks, 3 months and 12 months post treatment	Children´s Global Assessment Scale (CGAS)

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 15, 2026